Letter of concern to gov’t sparks quick ER responsesIn the wake of Dr. Paul Parks’ now famous e-mail outlining concern over ER overcrowding, the province has made some progress on the issue. Managing recurrent UTIs in womenThe Society of Obstetricians and Gynaecologists of Canada updates guidelines on treatment, prevention of recurrent urinary tract infections in women. Oakville Hospital receives $3.5-million donation Thelin (sitaxsentan): PAH drug withdrawn worldwide Pfizer Canada is voluntarily withdrawing Thelin from the market worldwide due to concerns about hepatotoxicity. Arthritis biologics may cut Alzheimer’s risk Colchicine safe for patients with comorbidities Early treatment improves outcomes in rheumatoid arthritis Methotrexate-prednisone combo achieves remission in nearly two-thirds of patients Impotency drug cures Raynaud’s fingertip ulcers Lowering urate cuts cardiovascular deaths Hyperuricemia deserves more aggressive treatment, researcher says Rheumatoid arthritis biologics may provoke shingles outbreaks Researchers advise clinicians to be vigilant when prescribing anti-TNF therapy RxA and province resume talks On Dec. 1, talks around the Alberta Pharmaceutical Strategy resumed as Alberta’s Pharmacy Transition Team met to discuss the Alberta Pharmaceutical Strategy. CPhA survey confirms drug shortages causing havoc Some pharmacists spending three hours per shift addressing shortages, research finds. First Previous 913 914 915 916 917 Next Last
